Mason Frazier, M.D., associate professor in the University of Alabama at Birmingham’s Marnix E. Heersink School of Medicine’s Department of Radiology, says contrast imaging is important part of ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has launched Gadoterate Meglumine Injection, USP, a bioequivalent and therapeutic equivalent substitute for the contrast agent ...
CHALFONT ST GILES, England--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) has approved Clariscan™, a macrocyclic, ionic, gadolinium-based, MRI contrast agent, expanding the GE ...
The Contrast Media Market is expected to experience a steady growth rate of 5-6% CAGR. Key drivers of this growth include innovations in imaging technologies, the rising incidence of chronic ...
January 17, 2011 — GE Healthcare has announced Food and Drug Administration (FDA) approval of ioflupane iodine-123 injection (DaTscan), a contrast agent for use with single-photon emission computed ...
Azurity Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved FerabrightTM ...
Leading experts provide guidance on alternative methods and case prioritization strategies to optimize available supplies in Journal of Vascular and Interventional Radiology “As interventionalists, ...
Researchers from Oxford University have reported a breakthrough in developing faster, contrast-free cardiovascular magnetic resonance (CMR). Their procedure uses a new artificial intelligence (AI) ...
The intrinsic nature of many astronomical objects, such as binary and multiple systems, exoplanets, circumstellar and debris disks, and quasar host galaxies, introduces challenging requirements for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback